关注
Alejandro Gonzalez-Serna
Alejandro Gonzalez-Serna
Hospital Universitario Virgen de Valme & University of Seville
在 us.es 的电子邮件经过验证
标题
引用次数
引用次数
年份
HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure
LC Swenson, JE Min, CK Woods, E Cai, JZ Li, JSG Montaner, ...
Aids 28 (8), 1125-1134, 2014
1132014
Performance of HIV-1 drug resistance testing at low-level viremia and its ability to predict future virologic outcomes and viral evolution in treatment-naive individuals
A Gonzalez-Serna, JE Min, C Woods, D Chan, VD Lima, JSG Montaner, ...
Clinical infectious diseases 58 (8), 1165-1173, 2014
1002014
Different biological significance of sCD14 and LPS in HIV-infection: importance of the immunovirology stage and association with HIV-disease progression markers
MC Romero-Sánchez, A González-Serna, YM Pacheco, ...
Journal of Infection 65 (5), 431-438, 2012
662012
Rapid decrease in peripheral blood mononucleated cell telomere length after HIV seroconversion, but not HCV seroconversion
A Gonzalez-Serna, A Ajaykumar, I Gadawski, MA Muñoz-Fernández, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 76 (1), e29-e32, 2017
372017
Correlation between the Trofile® test and virological response to a short-term maraviroc exposure in HIV-infected patients
M Genebat, E Ruiz-Mateos, JA Leon, A Gonzalez-Serna, I Pulido, I Rivas, ...
Journal of antimicrobial chemotherapy 64 (4), 845-849, 2009
342009
COVID‐19 in hospitalized HIV‐positive and HIV‐negative patients: A matched study
C Díez, J Del Romero‐Raposo, R Mican, JC López, JR Blanco, ...
HIV medicine 22 (9), 867-876, 2021
322021
A single untimed plasma drug concentration measurement during low-level HIV viremia predicts virologic failure
A Gonzalez-Serna, LC Swenson, B Watson, W Zhang, A Nohpal, ...
Clinical Microbiology and Infection 22 (12), 1004. e9-1004. e16, 2016
302016
Temporal trends in the discontinuation of first-line antiretroviral therapy
A Gonzalez-Serna, K Chan, B Yip, W Chau, R McGovern, H Samji, ...
Journal of Antimicrobial Chemotherapy 69 (8), 2202-2209, 2014
302014
TROCAI (tropism coreceptor assay information): a new phenotypic tropism test and its correlation with Trofile enhanced sensitivity and genotypic approaches
A Gonzalez-Serna, M Leal, M Genebat, MA Abad, A Garcia-Perganeda, ...
Journal of clinical microbiology 48 (12), 4453-4458, 2010
302010
Correlation of the virological response to short-term maraviroc monotherapy with standard and deep-sequencing-based genotypic tropism prediction methods
A Gonzalez-Serna, RA McGovern, PR Harrigan, F Vidal, AFY Poon, ...
Antimicrobial agents and chemotherapy 56 (3), 1202-1207, 2012
282012
Effect of maraviroc on HIV disease progression-related biomarkers
MC Romero-Sánchez, K Machmach, A Gonzalez-Serna, M Genebat, ...
Antimicrobial agents and chemotherapy 56 (11), 5858-5864, 2012
252012
High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment
J Macias, A Pinilla, FA Lao-Dominguez, A Corma, E Contreras-Macias, ...
Scientific Reports 10 (1), 20958, 2020
212020
Long-term immunovirogical effect and tolerability of a maraviroc-containing regimen in routine clinical practice
M Genebat, E Ruiz-Mateos, I Pulido, A Gonzalez-Serna, ...
Current HIV Research 8 (6), 482-486, 2010
212010
Maintenance of virologic efficacy and decrease in levels of β2-microglobulin, soluble CD40L and soluble CD14 after switching previously treated HIV-infected patients to an NRTI …
MC Romero-Sánchez, AI Álvarez-Ríos, E Bernal-Morell, M Genebat, ...
Antiviral research 111, 26-32, 2014
162014
Incidence of recently acquired hepatitis C virus infection among HIV‐infected patients in southern Spain
A Gonzalez‐Serna, J Macias, R Palacios, C Gómez‐Ayerbe, F Tellez, ...
HIV medicine 22 (5), 379-386, 2021
142021
Virological response after short-term CCR5 antagonist exposure in HIV-infected patients: frequency of subjects with virological response and associated factors
E Ruiz-Mateos, A González-Serna, M Genebat, K Machmach, F Vidal, ...
Antimicrobial agents and chemotherapy 55 (10), 4664-4669, 2011
132011
Discordance rates between Trofile® test and short-term virological response to maraviroc
M Genebat, E Ruiz-Mateos, A González-Serna, I Pulido, ...
Antiviral research 89 (2), 182-185, 2011
132011
Similar incidence of Coronavirus Disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy
PD Juan Macías, MD, MD Paz González-Moreno, ...
medRxiv 20104141 (https://doi.org/10.1101/2020.05.16.2010), 20104141, 2020
11*2020
Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events
J Martínez-Sanz, J Díaz-Álvarez, M Rosas, R Ron, JA Iribarren, E Bernal, ...
EBioMedicine 95, 2023
92023
Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study
B Alejos, I Suárez-García, M Rava, A Bautista-Hernández, F Gutierrez, ...
Journal of Antimicrobial Chemotherapy 75 (10), 3004-3014, 2020
92020
系统目前无法执行此操作,请稍后再试。
文章 1–20